[Idiopathic oedema].
Courtnadge C, Madsen F, Bygum A.
Ugeskr Laeger. 2017 Nov 27;179(48):V06170450.
Retropharyngeal oedema as an atypical presentation of multiple inflammatory syndrome in children.
Jensen MK, Kjærsgaard JB.
Ugeskr Laeger. 2022 Oct 31;184(44):V05220322.
Edema after CNS Trauma: A Focus on Spinal Cord Injury.
Seblani M, Decherchi P, Brezun JM.
Int J Mol Sci. 2023 Apr 12;24(8):7159. doi: 10.3390/ijms24087159.
Ultrasound scanning.
Joseph AE.
Scand J Gastroenterol Suppl. 1994;203:24-7. doi: 10.3109/00365529409091392.
Anti-inflammatory effects of novel sinomenine derivatives.
Zhao Z, Xiao J, Wang J, Dong W, Peng Z, An D.
Int Immunopharmacol. 2015 Dec;29(2):354-360. doi: 10.1016/j.intimp.2015.10.030. Epub 2015 Oct 31.
Vascular control of inflammatory oedema.
Warren JB.
Clin Sci (Lond). 1993 Jun;84(6):581-4. doi: 10.1042/cs0840581.
Inflammatory oedema of nerve trunks may be pathogenic in very early Guillain-Barre syndrome.
Berciano J.
Acta Neurol Belg. 2020 Oct;120(5):1061-1065. doi: 10.1007/s13760-020-01413-3. Epub 2020 Jun 18.
Primary bone marrow oedema syndromes.
Patel S.
Rheumatology (Oxford). 2014 May;53(5):785-92. doi: 10.1093/rheumatology/ket324. Epub 2013 Sep 29.
Novel association of chilblains with inflammatory arthritis- series of three cases and review of literature.
Joshi N, Ullah S, Shah A, Dubey S.
Rheumatol Int. 2025 Apr 2;45(4):85. doi: 10.1007/s00296-025-05840-4.
Novel alantolactone derivative AL-04 exhibits potential anti-inflammatory activity via modulation of iNOS, COX-2 and NF-kappaB.
Kumar A, Kour G, Chibber P, Saroch D, Kumar C, Ahmed Z.
Cytokine. 2022 Oct;158:155978. doi: 10.1016/j.cyto.2022.155978. Epub 2022 Jul 31.
